Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

"Acetaminophen poisoning" suit judgment awarded to McNeil by Florida jury.

This article was originally published in The Tan Sheet

Executive Summary

"ACETAMINOPHEN POISONING" SUIT JUDGMENT AWARDED TO McNEIL by a recent jury verdict in Tampa, Fla. In the case of Domke v. McNeil, "it is ordered and adjudged that plaintiffs take nothing, that the action be dismissed on the merits, and that each party bear its own costs of the action," the verdict states. The plaintiff, Rose Domke, representing her deceased husband, alleged that McNeil failed to warn consumers who regularly consume alcohol about the potential risk of taking acetaminophen. The suit is one of a number of cases claiming "acetaminophen poisoning" among regular drinkers of alcohol.

You may also be interested in...



J&J Argument Against Liver Damage Experts 'Borders On Ridiculous' – Judge

J&J fails in request to exclude two experts for the plaintiff in bellwether litigation alleging liver damage from indicated doses of Tylenol Extra Strength. The decision represents the second blow in less than a month in J&J's efforts to exclude plaintiff's evidence from the trial.

J&J Argument Against Liver Damage Experts 'Borders On Ridiculous' – Judge

J&J fails in request to exclude two experts for the plaintiff in bellwether litigation alleging liver damage from indicated doses of Tylenol Extra Strength. The decision represents the second blow in less than a month in J&J's efforts to exclude plaintiff's evidence from the trial.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087053

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel